ESR2 and neoplasm: Niikawa et al first reported that intratumoral estradiol (an activator of ERβ) concentration was significantly higher than that of corresponding non-neoplastic lung tissues, and positively associated with tumor size and Ki-67 labeling index (LI) in ER-positive NSCLC tissues (8).